These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35578875)

  • 1. An
    Gajbhiye KR; Soni V
    Curr Drug Deliv; 2023; 20(7):961-977. PubMed ID: 35578875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ascorbic acid tethered polymeric nanoparticles enable efficient brain delivery of galantamine: An in vitro-in vivo study.
    Gajbhiye KR; Gajbhiye V; Siddiqui IA; Pilla S; Soni V
    Sci Rep; 2017 Sep; 7(1):11086. PubMed ID: 28894228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy.
    Saneja A; Kumar R; Singh A; Dhar Dubey R; Mintoo MJ; Singh G; Mondhe DM; Panda AK; Gupta PN
    Int J Pharm; 2017 Oct; 531(1):153-166. PubMed ID: 28823888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adriamycin release from poly(lactide-coglycolide)-polyethylene glycol nanoparticles: synthesis, and in vitro characterization.
    Davaran S; Rashidi MR; Pourabbas B; Dadashzadeh M; Haghshenas NM
    Int J Nanomedicine; 2006; 1(4):535-9. PubMed ID: 17722284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodegradable nanoparticles of mPEG-PLGA-PLL triblock copolymers as novel non-viral vectors for improving siRNA delivery and gene silencing.
    Du J; Sun Y; Shi QS; Liu PF; Zhu MJ; Wang CH; Du LF; Duan YR
    Int J Mol Sci; 2012; 13(1):516-533. PubMed ID: 22312268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the synthesis of mucus permeating nanocarriers.
    Bourganis V; Karamanidou T; Samaridou E; Karidi K; Kammona O; Kiparissides C
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):239-49. PubMed ID: 25661586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PLGA-PEG-RA-based polymeric micelles for tumor targeted delivery of irinotecan.
    Emami J; Maghzi P; Hasanzadeh F; Sadeghi H; Mirian M; Rostami M
    Pharm Dev Technol; 2018 Jan; 23(1):41-54. PubMed ID: 28608760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats.
    Li Y; Pei Y; Zhang X; Gu Z; Zhou Z; Yuan W; Zhou J; Zhu J; Gao X
    J Control Release; 2001 Apr; 71(2):203-11. PubMed ID: 11274752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and in vitro evaluation of doxorubicin-loaded Fe₃O₄ magnetic nanoparticles modified with biocompatible copolymers.
    Akbarzadeh A; Mikaeili H; Zarghami N; Mohammad R; Barkhordari A; Davaran S
    Int J Nanomedicine; 2012; 7():511-26. PubMed ID: 22334781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumors.
    Luo G; Yu X; Jin C; Yang F; Fu D; Long J; Xu J; Zhan C; Lu W
    Int J Pharm; 2010 Jan; 385(1-2):150-6. PubMed ID: 19825404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study the effects of PLGA-PEG encapsulated amphotericin B nanoparticle drug delivery system against Leishmania donovani.
    Kumar R; Sahoo GC; Pandey K; Das V; Das P
    Drug Deliv; 2015 May; 22(3):383-8. PubMed ID: 24601828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-circulatory nanoparticles for gemcitabine delivery: Development and investigation of pharmacokinetics and in-vivo anticancer efficacy.
    Khare V; Singh A; Mahajan G; Alam N; Kour S; Gupta M; Kumar A; Singh G; Singh SK; Saxena AK; Mondhe DM; Gupta PN
    Eur J Pharm Sci; 2016 Sep; 92():183-93. PubMed ID: 27404580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen delivery via hydrophilic PEG-b-PAGE-b-PLGA nanoparticles boosts vaccination induced T cell immunity.
    Rietscher R; Schröder M; Janke J; Czaplewska J; Gottschaldt M; Scherließ R; Hanefeld A; Schubert US; Schneider M; Knolle PA; Lehr CM
    Eur J Pharm Biopharm; 2016 May; 102():20-31. PubMed ID: 26940132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endostar-loaded PEG-PLGA nanoparticles: in vitro and in vivo evaluation.
    Hu S; Zhang Y
    Int J Nanomedicine; 2010 Nov; 5():1039-48. PubMed ID: 21170352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro drug release behavior, mechanism and antimicrobial activity of rifampicin loaded low molecular weight PLGA-PEG-PLGA triblock copolymeric nanospheres.
    Gajendiran M; Divakar S; Raaman N; Balasubramanian S
    Curr Drug Deliv; 2013 Dec; 10(6):722-31. PubMed ID: 23701139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Nanoparticles for Drug Delivery to Brain Tumor: The Effect of Surface Materials on Penetration Into Brain Tissue.
    Lei C; Davoodi P; Zhan W; Chow PK; Wang CH
    J Pharm Sci; 2019 May; 108(5):1736-1745. PubMed ID: 30552956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspartic acid-based modified PLGA-PEG nanoparticles for bone targeting: in vitro and in vivo evaluation.
    Fu YC; Fu TF; Wang HJ; Lin CW; Lee GH; Wu SC; Wang CK
    Acta Biomater; 2014 Nov; 10(11):4583-4596. PubMed ID: 25050775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific cellular internalization and pH-responsive behavior of doxorubicin loaded PLGA-PEG nanoparticles targeted with anti EGFRvIII antibody.
    Eivazi N; Rahmani R; Paknejad M
    Life Sci; 2020 Nov; 261():118361. PubMed ID: 32861796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymeric nanoparticles for drug delivery.
    Chan JM; Valencia PM; Zhang L; Langer R; Farokhzad OC
    Methods Mol Biol; 2010; 624():163-75. PubMed ID: 20217595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of size-tunable sub-200 nm PLGA-based nanoparticles with a wide size range using a microfluidic platform.
    Bao Y; Maeki M; Ishida A; Tani H; Tokeshi M
    PLoS One; 2022; 17(8):e0271050. PubMed ID: 35925917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.